Form D — Abingworth Clinical Co-Development Fund 3 LP
0002049495-25-000001 · filed 2025-06-25
Offering
- Industry
- Pooled Investment Fund
- Exemptions
- 06c, 3C, 3C.7
- Total offering
- —
- Total sold
- $0
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Abingworth Clinical Co-Development Fund 3 LP
- CIK
- 2049495
- Entity
- Limited Partnership
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 1001 PENNSYLVANIA AVENUE, NW
WASHINGTON, DC 20004 - Phone
- 202-729-5626
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
N/A ACCD 3 GP LP · PromoterWashington, DC Find on LinkedIn ↗
-
N/A ACCD 3 Holdings, L.L.C. · PromoterWashington, DC Find on LinkedIn ↗
-
David Lobe · Executive OfficerWashington, DC Find on LinkedIn ↗
-
Jeremy Anderson · Executive OfficerWashington, DC Find on LinkedIn ↗
-
Robert Rosen · Executive OfficerWashington, DC Find on LinkedIn ↗
-
Christina Gibbs · Executive OfficerWashington, DC Find on LinkedIn ↗
View original on SEC EDGAR.